Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1668 | 2545 | 32.9 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
118 | 3 | EPSTEIN BARR VIRUS//LYMPHOMA//HODGKINS DISEASE | 69002 |
495 | 2 | EPSTEIN BARR VIRUS//NASOPHARYNGEAL CARCINOMA//HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS | 15379 |
1668 | 1 | POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER//PTLD//POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE | 2545 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER | authKW | 2162526 | 9% | 78% | 231 |
2 | PTLD | authKW | 1639375 | 7% | 79% | 173 |
3 | POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE | authKW | 1016939 | 5% | 74% | 115 |
4 | EPSTEIN BARR VIRUS | authKW | 690718 | 21% | 11% | 530 |
5 | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER | authKW | 565688 | 3% | 65% | 73 |
6 | POST TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER | authKW | 562336 | 2% | 76% | 62 |
7 | LYMPHOPROLIFERATIVE DISORDERS | authKW | 267513 | 5% | 19% | 116 |
8 | EBV | authKW | 236837 | 7% | 12% | 170 |
9 | POST TRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE | authKW | 165086 | 1% | 81% | 17 |
10 | LYMPHOPROLIFERATIVE DISEASE | authKW | 163812 | 2% | 27% | 50 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Transplantation | 57863 | 31% | 1% | 799 |
2 | Hematology | 7667 | 17% | 0% | 439 |
3 | Immunology | 7653 | 27% | 0% | 692 |
4 | Surgery | 5375 | 26% | 0% | 657 |
5 | Pathology | 2261 | 9% | 0% | 229 |
6 | Oncology | 1744 | 15% | 0% | 389 |
7 | Pediatrics | 1142 | 8% | 0% | 209 |
8 | Virology | 540 | 4% | 0% | 102 |
9 | Urology & Nephrology | 401 | 4% | 0% | 112 |
10 | Infectious Diseases | 198 | 3% | 0% | 87 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOINT ONCOL PROGRAM | 43170 | 0% | 30% | 12 |
2 | EBV BIOL | 33319 | 0% | 56% | 5 |
3 | CELL GENE THER Y | 28927 | 2% | 4% | 59 |
4 | CLIN IMMUNOHAEMATOL | 24483 | 0% | 29% | 7 |
5 | HOSP VOGHERA | 23993 | 0% | 100% | 2 |
6 | HUMAN PATHOLANAT PATHOL SECT | 23993 | 0% | 100% | 2 |
7 | OPERAT TEAM QUAL MANAGEMENT | 23993 | 0% | 100% | 2 |
8 | PEDIAT HAEMATOL ONCOL S | 23993 | 0% | 100% | 2 |
9 | VIROL MICROBIOL MED BIOTECHNOL | 23993 | 0% | 100% | 2 |
10 | AUSTRALIAN VACCINE DEV | 17048 | 0% | 18% | 8 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TRANSPLANTATION | 26197 | 8% | 1% | 201 |
2 | PEDIATRIC TRANSPLANTATION | 24123 | 3% | 3% | 68 |
3 | AMERICAN JOURNAL OF TRANSPLANTATION | 14113 | 3% | 2% | 75 |
4 | CLINICAL TRANSPLANTATION | 9343 | 2% | 1% | 54 |
5 | TRANSPLANTATION PROCEEDINGS | 7567 | 6% | 0% | 161 |
6 | BONE MARROW TRANSPLANTATION | 4659 | 2% | 1% | 59 |
7 | EXPERIMENTAL AND CLINICAL TRANSPLANTATION | 4479 | 1% | 2% | 19 |
8 | TRANSPLANT INFECTIOUS DISEASE | 4133 | 1% | 2% | 20 |
9 | LEUKEMIA & LYMPHOMA | 3871 | 2% | 1% | 50 |
10 | ANNALS OF TRANSPLANTATION | 2794 | 1% | 2% | 13 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LAURO, A , ARPINATI, M , PINNA, AD , (2015) MANAGING THE CHALLENGE OF PTLD IN LIVER AND BOWEL TRANSPLANT RECIPIENTS.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 169. ISSUE 2. P. 157 -172 | 107 | 85% | 1 |
2 | GULLEY, ML , TANG, WH , (2010) USING EPSTEIN-BARR VIRAL LOAD ASSAYS TO DIAGNOSE, MONITOR, AND PREVENT POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER.CLINICAL MICROBIOLOGY REVIEWS. VOL. 23. ISSUE 2. P. 350 -+ | 124 | 67% | 82 |
3 | GROSS, TG , SAVOLDO, B , PUNNETT, A , (2010) POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASES.PEDIATRIC CLINICS OF NORTH AMERICA. VOL. 57. ISSUE 2. P. 481-+ | 107 | 87% | 16 |
4 | MYNAREK, M , SCHOBER, T , BEHRENDS, U , MAECKER-KOLHOFF, B , (2013) POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE AFTER PEDIATRIC SOLID ORGAN TRANSPLANTATION.CLINICAL & DEVELOPMENTAL IMMUNOLOGY. VOL. . ISSUE . P. - | 104 | 83% | 7 |
5 | BAKKER, NA , VAN IMHOFF, GW , VERSCHUUREN, EAM , VAN SON, WJ , (2007) PRESENTATION AND EARLY DETECTION OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER AFTER SOLID ORGAN TRANSPLANTATION.TRANSPLANT INTERNATIONAL. VOL. 20. ISSUE 3. P. 207-218 | 97 | 91% | 63 |
6 | DHARNIDHARKA, VR , WEBSTER, AC , MARTINEZ, OM , PREIKSAITIS, JK , LEBLOND, V , CHOQUET, S , (2016) POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS.NATURE REVIEWS DISEASE PRIMERS. VOL. 2. ISSUE . P. - | 114 | 61% | 2 |
7 | JAGADEESH, D , WODA, BA , DRAPER, J , EVENS, AM , (2012) POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: RISK, CLASSIFICATION, AND THERAPEUTIC RECOMMENDATIONS.CURRENT TREATMENT OPTIONS IN ONCOLOGY. VOL. 13. ISSUE 1. P. 122-136 | 71 | 97% | 61 |
8 | AL-MANSOUR, Z , NELSON, BP , EVENS, AM , (2013) POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD): RISK FACTORS, DIAGNOSIS, AND CURRENT TREATMENT STRATEGIES.CURRENT HEMATOLOGIC MALIGNANCY REPORTS. VOL. 8. ISSUE 3. P. 173-183 | 82 | 91% | 19 |
9 | SAN-JUAN, R , COMOLI, P , CAILLARD, S , MOULIN, B , HIRSCH, HH , MEYLAN, P , (2014) EPSTEIN-BARR VIRUS-RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN SOLID ORGAN TRANSPLANT RECIPIENTS.CLINICAL MICROBIOLOGY AND INFECTION. VOL. 20. ISSUE . P. 109 -118 | 71 | 89% | 15 |
10 | STYCZYNSKI, J , (2017) MANAGING POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER.EXPERT OPINION ON ORPHAN DRUGS. VOL. 5. ISSUE 1. P. 19 -35 | 86 | 76% | 0 |
Classes with closest relation at Level 1 |